Aeterna Zentaris Inc.
(Toronto Stock Exchange : AEZS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.11%80.040.9%$597.08m
CELGCelgene Corporation
1.70%139.041.1%$557.36m
AMGNAmgen Inc.
1.02%183.761.1%$431.88m
BIIBBiogen Inc.
3.44%347.211.2%$381.11m
REGNRegeneron Pharmaceuticals, Inc.
-0.02%445.612.7%$321.83m
ALNYAlnylam Pharmaceuticals, Inc
-1.49%120.0710.7%$266.04m
VRTXVertex Pharmaceuticals Incorporated
0.20%155.011.9%$226.32m
INCYIncyte Corporation
-0.57%115.932.5%$208.50m
ALXNAlexion Pharmaceuticals, Inc.
2.58%144.481.9%$182.89m
ILMNIllumina, Inc.
-0.38%205.443.5%$140.54m
EXELExelixis, Inc.
0.26%29.106.5%$134.60m
CLVSClovis Oncology, Inc.
-3.81%81.3616.5%$126.34m
BLUEBluebird Bio, Inc.
-2.72%139.4017.3%$118.68m
SRPTSarepta Therapeutics, Inc.
1.24%51.3616.9%$112.07m
BMRNBioMarin Pharmaceutical Inc.
0.23%94.884.4%$105.01m

Company Profile

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. It focuses on the development of Perifosine, Cetrotide, Ozarelix, AEZS-108 and AEZS-130. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Montreal, Canada.